Strategic Analysis of Biomarkers in Clinical Trials
Strategic Analysis of Biomarkers in Clinical Trials
RELEASE DATE
29-Oct-2004
29-Oct-2004
REGION
Global
Global
Research Code: B451-01-00-00-00
SKU: HC01066-GL-MR_05093
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC01066-GL-MR_05093
Description
This strategic analysis service provides detailed analysis of the role of biomarkers in clincal trials. The service in powerpoint format (approximately 136 slides) focuses not just only on overall market revenues and competitor analysis but also on strategies for achieving success in this new and emerging market.
Table of Contents
Overview
- Overview
Research Scope & Methodology
- Research Scope & Methodology
Introduction & Background
- Introduction & Background
Market Dynamics
- Market Dynamics
- Major Challenges for Biomarkers in Clinical Trials
- Key Market Trends
- Market Drivers
- Market Restraints
- Key Market Engineering Measurements
- Total Market Revenue Forecast
Regulatory Climate
- Regulatory Climate
- Drug Failure in Clinical Development
- Decrease in FDA Submissions
- Decrease in EMEA Submissions
- Current FDA Policy
Research Trends
- Research Trends
- Assumptions
- World Biomarker Research Direction
- World Investment in Research and Development
- World Biomarker IP Portfolios
- Competitive Profiles
- Other Key Industry Participants
Major Challenges & Strategic Proposals
- Major Challenges and Strategic Proposals
- Biomarker Misdiagnosis Issues
- Investment in Biomarkers
- Clinical Development Productivity Improvement
- Biomarker Regulatory Issues
- Late Stage Clinical Failure
- Summary of Strategic Proposals
Corporate Strategy
- Corporate Strategy
- Corporate Strategy—Strategic Anticipation
- Corporate Strategy—Market Maturation Process
- Corporate Strategy—Competitive Framework
- Corporate Strategy—Potential Threats
- Corporate Strategy—Meeting the Challenge
Frost & Sullivan Awards
- Frost & Sullivan Awards
- Frost & Sullivan Awards Description
- Growth Strategy Leadership Award
- Technology Leadership Award
- Entrepreneurial Company Award
- Market Leadership Award
- Competitive Strategy Leadership Award
Decision Support Databases
- Decision Support Databases
- New Drugs Approved by the FDA (2000-2004)
- New Drugs Approved by the EMEA (2000-2004)
- Number of Biotechnology Companies—Western Europe and North America (1999-2006)
- Major Pharmaceutical Companies in Europe (2003)
- Biotechnology European Patents Filed (1996-2000)
- Governmental Biotechnology Investment (1999-2006)
- Pharmaceutical Research and Development Expenditure (1999-2006)
Frost & Sullivan
- Healthcare Team
- Our Capabilities
Popular Topics
This strategic analysis service provides detailed analysis of the role of biomarkers in clincal trials. The service in powerpoint format (approximately 136 slides) focuses not just only on overall market revenues and competitor analysis but also on strategies for achieving success in this new and emerging market.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | B451-01-00-00-00 |
Is Prebook | No |